Microbial Pathogenesis 2019

Oct 23-24, 2019

Tokyo, Japan

Conference on Microbial Pathogenesis & Antibiotic Resistance in 2019 in Tokyo, Japan

We are delighted to announce Pharmaceutical Microbiology & Antimicrobial Agents Summit in Tokyo, Japan during October 23-24, 2019. This conference has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industries belonging to Biotech and Pharmaceuticals sectors and academia.

Pharmaceutical Microbiology is an applied branch of microbiology which mainly involves pharmacokinetic and pharmacodynamic properties of the drug prepared from the micro-organisms. The other aspects are research and advanced developments of anti- infective agents and the use of microbes in detecting mutagenic and carcinogenic activity in prospective drugs and in production of pharmaceuticals products like insulin and human growth hormones. There are certain aspects that to be followed in pharmaceuticals like drug safety and shelf life of the drug, etc.

Pharmaceutical Microbiology summit is to widen the science and technology in such a way to provide an exclusive platform for educators, new researchers, and learners to present and discuss the most recent innovations, possibilities, and concerns adopted in the field. This summit covers academic reports, research methods, thesis work, summary of literatures, and scientific and technological writings. The conference will comprise an informative and exciting program including leading keynote speakers, poster presenters, session speakers who will be presenting their research on the topics related.

Therefore to acquire all this knowledge we invite you heartedly to join us at the Pharmaceutical Microbiology, where you will be sure to have a great experience with experts from around the world.

Why to attend:

  • Platform to access incredible speakers, experts and influencers face to face .
  • Opportunity to grab tips and tactics from leading industrialists and eminent speakers in the fields of Pharmacy, Microbiology and Drug Development.
  • Opportunity to share and explore your research ideas to be more productive .
  • Chance to collaborate with global business delegates and researchers.
  • This conference acts as a dais for introducing new ideas and approaches.


Details of Pharmaceutical Microbiology and Antimicrobial Agents in 2019 in Tokyo, Japan :

Conference Name



Pharmaceutical Microbiology Conference 2019

Tokyo, Japan

Oct 23-24, 2019


Why Japan?

The pharmaceutical market in Japan has shown small growth rates in the past years. A complex regulatory and pricing process, as well as the regular price cuts have made it difficult for pharmaceutical companies to introduce new innovative products. Another reason for the stagnant market is the promotion of generic drugs adopted by the government since 2007 in order to reduce the healthcare expenditures in Japan. The volume share of generics has almost doubled during the last decade and is still on the rise. Moreover, as many drug patents expire in the near future, Japanese companies are forced to adapt to a changing market environment.

Additionally, the Japanese government has been working to reduce long approval processes for new products faced by pharma companies, which will also have the positive effect of attracting foreign companies. But not only international companies seeking to invest in the Japanese market, also growing pharmaceutical exports from Japan will help strengthening the pharma industry.

Along with the changing industry landscape and the flourishing market for generic drugs, the projected transformation of the Japanese pharma industry will be driven by the increased use of biosimilars that are expected to be the fastest growing sector in the future with a variety of products currently under development. While biopharmaceuticals account for about one third in the world market, products make up only around ten percent in the Japanese biopharmaceutical market, indicating potential for growth.

Program Overview